CRITERIUM INC. CHOOSES OMNICOMM SYSTEMS, INC. FOR ELECTRONIC DATA CAPTURE (EDC) SOFTWARE AND SERVICES AND JOINS THE CRO PREFERRED PROGRAM™

Veteran Contract Research Organization (CRO) recommends TrialMaster™ for EDC

FT. LAUDERDALE, FL – April 8, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Criterium Inc., the full service, global, technology driven contract research organization has become a member of OmniComm’s CRO Preferred Program. The partnership allows Criterium to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster for clinical trials. Criterium will also benefit from the CRO program’s distinct advantages that include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm in the selection process, a dedicated, hosted environment and comprehensive training and support for TrialMaster.

“Criterium has been in the business of providing high-quality, global clinical trial support services to the drug development industry for nearly 20 years. We have had the opportunity to become familiar with many of the EDC systems in the marketplace and have chosen TrialMaster based on its superior functionality and compatibility with Criterium’s StudyControl™, our centralized clinical trial data management environment,” said John Hudak, President and Founder of Criterium. “We work successfully with OmniComm and TrialMaster, along with our other data sources, integrates seamlessly with our data management system. We appreciate the right mix of a superior EDC product and the real dedication to customer service that the OmniComm-Criterium team delivers.”

“We are honored that yet another prestigious CRO like Criterium has joined our very successful CRO Preferred Program. Companies are starting to realize the substantial benefits of this Program, such as the fixed pricing and complete marketing support that other vendors just don’t offer. Partnering with OmniComm allows CROs like Criterium to offer their customers a first class electronic data capture product and gives them a competitive edge in the bidding process,” said Stephen Johnson, COO of OmniComm. “It’s a win for everyone involved, the CRO, OmniComm and most importantly the clients that we serve.”

About Criterium
Criterium Inc. (www.criteriuminc.com) is a full service, global and technology driven contract research organization that offers a unique mix of high-quality, innovative clinical research solutions for the biopharmaceutical, and pharmaceutical, medical device and CRO industries. From thought to finish, Criterium provides timely and accurate clinical trial data and support services at every phase of development allowing customers to make sound and cost effective decisions about their clinical trials. Drug development companies can benefit from Criterium’s expertise, high-value services and products and high-end results. Founded in 1991, Criterium’s services are customized to fit each client’s specific needs, providing a seamless flow of data and information from the investigative site through Criterium back to the sponsor. To learn more about the Criterium Edge, visit the website. Criterium has corporate headquarters in Saratoga Springs, New York with offices in Florida, California, South Africa, India, Netherlands, Israel, Russia and Canada.

About OmniComm
OmniComm Systems, Inc. (www.omniComm.com), provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm’s growing base of satisfied customers is a direct result of the company’s commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm’s client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer
Statements about OmniComm’s future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm’s operations, markets and profitability, actual results could differ materially and adversely from the expected results.

CONTACT:
Lizanne Kelley
OmniComm Systems, Inc.
954-473-1254 Extension 283
lkelley@omnicomm.com

Back